OSE Immunotherapeutics SA
News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.OSE Immunotherapeutics SA is a biotechnology company. It develops immunotherapies which act on effector & suppressor cells to stimulate or inhibit body's immune response & to restore immune disorders in immuno-oncology, autoimmune & transplantation.
Latest OSE News